Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3892/or.2010.1086 http://scihub22266oqcxt.onion/10.3892/or.2010.1086 21152880!ä!21152880 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncol+Rep 2011 ; 25 (2): 399-407 Nephropedia Template TP {{tp|p=21152880|t=2011. Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma |pdf=|usr=}}{{21152880}} gab.com Text Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma JO: Oncol Rep http://www.kidney.de/pget.php?&tw=1&pmid=21152880 #FOAvip Aberrant DNA methylation and histone deacetylation participate in cancer development and progression; hence, their reversal by inhibitors of DNA methylation and histone deacetylases is a promising cancer therapy. Experimental data demonstrate that these inhibitors in combination do not only show synergy in antitumor effects but also in whole genome global expression. Ten pairs of pre- and post-treatment cervical tumor samples were analyzed by microarray analysis. Treatment for seven days with hydralazine and valproate (HV) in patients up-regulated 964 genes. The two pathways possessing the highest number of up-regulated genes comprised the ribosome protein and the oxidative phosphorylation pathways, followed by MAPK signaling, tight junction, adherens junction, actin cytoskeleton, cell cycle, focal adhesion, apoptosis, proteasome, Wnt signaling, and antigen processing and presentation pathways. Up-regulated genes by HV, clustered with down-regulated genes in untreated primary cervical carcinomas and were more alike as compared with up-regulated genes from untreated patients in terms of gene ontology. Increased acetylated p53 was also observed. Epigenetic therapy with HV leads to gene reactivation in primary tumors of cervical cancer patients as well as protein acetylation. A number of these reactivated genes have a definitive role as a tumor suppressors. The global expression pattern induced by HV suggests this therapy has an impact on pathways related to energy production which may promote apoptosis. Twit Text FOAVip Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma ????Oncol Rep http://www.kidney.de/pget.php?&tw=1&pmid=21152880 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=21152880 #FOAvip English Wikipedia <ref>{{Cite pmid|21152880}}</ref> Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma #MMPMID21152880 De la Cruz-Hernandez E; Perez-Plasencia C; Perez-Cardenas E; Gonzalez-Fierro A; Trejo-Becerril C; Chavez-Blanco A; Taja-Chayeb L; Vidal S; Gutierrez O; Dominguez GI; Trujillo JE; Duenas-Gonzalez A Oncol Rep 2011[Feb]; 25 (2): 399-407 PMID21152880show ga Aberrant DNA methylation and histone deacetylation participate in cancer development and progression; hence, their reversal by inhibitors of DNA methylation and histone deacetylases is a promising cancer therapy. Experimental data demonstrate that these inhibitors in combination do not only show synergy in antitumor effects but also in whole genome global expression. Ten pairs of pre- and post-treatment cervical tumor samples were analyzed by microarray analysis. Treatment for seven days with hydralazine and valproate (HV) in patients up-regulated 964 genes. The two pathways possessing the highest number of up-regulated genes comprised the ribosome protein and the oxidative phosphorylation pathways, followed by MAPK signaling, tight junction, adherens junction, actin cytoskeleton, cell cycle, focal adhesion, apoptosis, proteasome, Wnt signaling, and antigen processing and presentation pathways. Up-regulated genes by HV, clustered with down-regulated genes in untreated primary cervical carcinomas and were more alike as compared with up-regulated genes from untreated patients in terms of gene ontology. Increased acetylated p53 was also observed. Epigenetic therapy with HV leads to gene reactivation in primary tumors of cervical cancer patients as well as protein acetylation. A number of these reactivated genes have a definitive role as a tumor suppressors. The global expression pattern induced by HV suggests this therapy has an impact on pathways related to energy production which may promote apoptosis. |Antineoplastic Combined Chemotherapy Protocols/pharmacology/therapeutic use[MESH] |Carcinoma/drug therapy/*genetics/pathology[MESH] |Clinical Trials as Topic[MESH] |DNA Methylation/drug effects[MESH] |Epigenesis, Genetic/*drug effects[MESH] |Female[MESH] |Gene Expression Profiling[MESH] |Gene Expression Regulation, Neoplastic/drug effects[MESH] |Histone Deacetylase Inhibitors/administration & dosage/pharmacology[MESH] |Humans[MESH] |Hydralazine/administration & dosage/*pharmacology[MESH] |Microarray Analysis[MESH] |Transcription, Genetic/*drug effects[MESH] |Up-Regulation/drug effects/genetics[MESH] |Uterine Cervical Neoplasms/drug therapy/*genetics/pathology[MESH]Transcriptional changes induced by epigenetic therapy with hydralazine(epmc).pdf DeepDyve Pubget Overpricing